MSH2 and colorectal carcinoma: The MSH2 p.G692V variant, currently considered a VUS in ClinVar, was identified in a patient with metachronous CRC at 29 and 44 years demonstrating MSI-H and loss of MSH2/MSH6 protein expression, providing further support for variant pathogenicity.